PREA: Is triggered by an application for a new indication, new dosage form, a new dosing regimen, a new route of administration or a new active ingredient. Authorizes FDA to require a pediatric assessment of some approved drug/biologic products for certain indications.
What are the pediatric age groups?
The US Food and Drug Administration defines pediatric patients as aged up to 16 years only and uses fewer age categories but with their broader categories coinciding with the categories proposed, which are: neonates, 0 to 1 month; infants, 1 month to 2 years; children, 2 to 12 years; and adolescents, 12 to 16 years.
What are 4 year olds called?
4 is considered preschooler, and toddlers are 1 to 3.
What is gain exclusivity?
Non-patent exclusivities, such as GAIN exclusivity, provides 5 years of additional protection to the approved antibacterial and antifungal drugs to prevent generic entry into the market3,4. Lastly, the CDC helps in promoting education, innovation, and implementation of antibiotics stewardship programs.
How long is drug exclusivity?
Once a new drug is approved, the FDA provides a guaranteed period during which a generic version cannot be approved, regardless of the time remaining on the new drug’s patent. This regulatory exclusivity typically runs for at least six years for new drugs.
When do you submit iPSP?
A sponsor must submit an iPSP, if required under PREA, before the date on which the sponsor submits the required assessments or investigation and no later than either 60 calendar days after the date of the end-of-phase 2 meeting or such other time as agreed upon between FDA and the sponsor.
Which drugs do not need an FDA approval?
A few current (and some previously) unapproved medications include:
- colchicine.
- nitroglycerin tablets.
- morphine concentrated solution.
- morphine sulfate solution.
- phenobarbital.
- chloral hydrate.
- carbinoxamine.
- pheniramine maleate and dexbrompheniramine maleate (in cough and cold combination drugs)
What is gain act?
To incentivize the creation of new treatments, the US Congress enacted the Generating Antibiotic Incentives Now Act (GAIN Act) of 2012, which provides benefits to manufacturers of Qualified Infectious Disease Products (QIDPs) including 5 years of additional nonpatent exclusivity.
Can drug patents be renewed?
Patents filed since 1995 last for 20 years from the date of patent application filing. Sometimes patent duration can be extended, and pharmaceutical companies, which make about 80% of their overall revenue because of their patents, often try to extend patent terms for as long as they can.
